Literature DB >> 22541076

[Reversal effect of gambogic acid on multidrug resistance of K562/A02 cell line].

Liang Tian1, Juan Liu, Bao-An Chen, Jian Cheng, Jia-Hua Ding, Shuai Wang, Guo-Hua Xia, Feng Gao, Ze-Ye Shao, Hai-Jun Zhang, Qing-Long Guo, Hai-Wei Zhang, Lei Wang, Yan-Yan Ren, Xiao-Hui Cai, Ran Liu.   

Abstract

This study was purposed to investigate the reversal effect of gambogic acid (GA) on multidrug resistance of K562/A02 cells and its mechanism. The IC(50) (half maximal inhibitory concentration) of adriamycin (ADM) was evaluated by MTT. Cell apoptosis was detected by flow cytometry. Morphological changes of K562/A02 cells were observed by fluorescent microscopy with DAPI staining. The expressions of Survivin and P-gp were determined by Western blot. The results showed that the IC(50) of ADM on K562 and K562/A02 cell proliferation were (1.42 ± 0.07) µg/ml and (28.42 ± 1.40) µg/ml respectively. GA ≤ 0.0625 µmol/L had no inhibitory effect on proliferation of K562 and K562/A02. 0.0625 µmol/L GA could enhance the sensitivity of K562/A02 cells to ADM (P < 0.05) and the reversal multiples was 1.53. The apoptotic rate was raised after treating with ADM combined with 0.0625 µmol/L GA for 48 h (P < 0.05). Morphological differences were typical and obvious between cells of control and treated groups under fluorescence microscopy using DAPI staining. After treating K562/A02 cells with ADM combined with 0.0625 µmol/L GA for 48 h, the expressions of Survivin and P-gp were down-regulated at protein levels. It is concluded that GA can enhance the sensitivity of K562/A02 cells to ADM, which may be related to increasing cell apoptosis and down-regulating expressions of Survivin and P-gp.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22541076

Source DB:  PubMed          Journal:  Zhongguo Shi Yan Xue Ye Xue Za Zhi        ISSN: 1009-2137


  3 in total

Review 1.  Research Progress in the Field of Gambogic Acid and Its Derivatives as Antineoplastic Drugs.

Authors:  Meng Li; Fali Su; Mingtao Zhu; Huan Zhang; Yuxin Wei; Yang Zhao; Jianmin Li; Shaowa Lv
Journal:  Molecules       Date:  2022-05-04       Impact factor: 4.927

Review 2.  Research Progress on Reversing Multidrug Resistance in Tumors by Using Chinese Medicine.

Authors:  Huan-Dong Zhao; Hong-Juan Xie; Jian Li; Cai-Ping Ren; Yu-Xiang Chen
Journal:  Chin J Integr Med       Date:  2018-06-02       Impact factor: 1.978

3.  Combination of gambogic acid with cisplatin enhances the antitumor effects on cisplatin-resistant lung cancer cells by downregulating MRP2 and LRP expression.

Authors:  Wendian Zhang; Hechao Zhou; Ying Yu; Jingjing Li; Haiwen Li; Danxian Jiang; Zihong Chen; Donghong Yang; Zumin Xu; Zhonghua Yu
Journal:  Onco Targets Ther       Date:  2016-06-02       Impact factor: 4.147

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.